Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Hepatology
|
November 3, 2001
Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C
U Düesberg, A M Schneiders, D Flieger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 5, 2000
Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12
D Flieger, U Spengler, I Beier, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 13, 1990
[Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type]
R Schlag, D Flieger, H W Ziegler-Heitbrock, et al.
Der Pathologe
|
May 5, 2012
[Rectal goblet cell carcinoid. Primary tumor or metastasis?]
K Krümpelmann, T Hansen, W Fried-Proell, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1992
Gangliosides suppress tumor necrosis factor production in human monocytes
H W Ziegler-Heitbrock, E Käfferlein, J G Haas, et al.
Hybridoma
|
April 22, 1999
Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines
D Flieger, U Spengler, I Beier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction
M Moehler, S Kanzler, M Geissler, et al.
Gene
|
November 16, 1992
Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the alpha-chain of the human interleukin-2 receptor
W Weissenhorn, W Scheuer, B Kaluza, et al.
British Journal of Cancer
|
June 9, 2005
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
M Moehler, A Eimermacher, J Siebler, et al.
Human Gene Therapy
|
February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial
B Wittig, A Märten, T Dorbic, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Hepatology
|
November 3, 2001
Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C
U Düesberg, A M Schneiders, D Flieger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 5, 2000
Augmentation of 17-1A-induced antibody-dependent cellular cytotoxicity by the triple cytokine combination of interferon-alpha, interleukin-2, and interleukin-12
D Flieger, U Spengler, I Beier, et al.
Deutsche Medizinische Wochenschrift (1946)
|
July 13, 1990
[Interferon alfa-2B in chronic lymphatic leukemia of the B-cell type]
R Schlag, D Flieger, H W Ziegler-Heitbrock, et al.
Der Pathologe
|
May 5, 2012
[Rectal goblet cell carcinoid. Primary tumor or metastasis?]
K Krümpelmann, T Hansen, W Fried-Proell, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1992
Gangliosides suppress tumor necrosis factor production in human monocytes
H W Ziegler-Heitbrock, E Käfferlein, J G Haas, et al.
Hybridoma
|
April 22, 1999
Enhancement of antibody dependent cellular cytotoxicity (ADCC) by combination of cytokines
D Flieger, U Spengler, I Beier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction
M Moehler, S Kanzler, M Geissler, et al.
Gene
|
November 16, 1992
Combinatorial functions of two chimeric antibodies directed to human CD4 and one directed to the alpha-chain of the human interleukin-2 receptor
W Weissenhorn, W Scheuer, B Kaluza, et al.
British Journal of Cancer
|
June 9, 2005
Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
M Moehler, A Eimermacher, J Siebler, et al.
Human Gene Therapy
|
February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial
B Wittig, A Märten, T Dorbic, et al.
Page
of 3